DE69936780D1 - Antikörper gegen eine lar-phosphatase untereinheit - Google Patents

Antikörper gegen eine lar-phosphatase untereinheit

Info

Publication number
DE69936780D1
DE69936780D1 DE69936780T DE69936780T DE69936780D1 DE 69936780 D1 DE69936780 D1 DE 69936780D1 DE 69936780 T DE69936780 T DE 69936780T DE 69936780 T DE69936780 T DE 69936780T DE 69936780 D1 DE69936780 D1 DE 69936780D1
Authority
DE
Germany
Prior art keywords
antibodies
lar
sub
unit
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69936780T
Other languages
English (en)
Other versions
DE69936780T2 (de
Inventor
Hiroshi Yamamoto
Kazutake Tsujikawa
Yukiko Uchino
Noboru Konishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuso Pharmaceutical Industries Ltd
Original Assignee
Fuso Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Industries Ltd filed Critical Fuso Pharmaceutical Industries Ltd
Publication of DE69936780D1 publication Critical patent/DE69936780D1/de
Application granted granted Critical
Publication of DE69936780T2 publication Critical patent/DE69936780T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69936780T 1998-06-08 1999-06-07 Antikörper gegen eine lar-phosphatase untereinheit Expired - Lifetime DE69936780T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/JP98/02542 1998-06-08
JP9802542 1998-06-08
PCT/JP1999/003054 WO1999064591A1 (fr) 1998-06-08 1999-06-07 Anticorps contre une sous-unite de phosphatase lar

Publications (2)

Publication Number Publication Date
DE69936780D1 true DE69936780D1 (de) 2007-09-20
DE69936780T2 DE69936780T2 (de) 2008-06-05

Family

ID=14208367

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69936780T Expired - Lifetime DE69936780T2 (de) 1998-06-08 1999-06-07 Antikörper gegen eine lar-phosphatase untereinheit

Country Status (9)

Country Link
US (3) US6846912B1 (de)
EP (2) EP1092772B1 (de)
JP (1) JP3991327B2 (de)
KR (1) KR100501550B1 (de)
AT (1) ATE369425T1 (de)
AU (1) AU752642B2 (de)
CA (1) CA2329776C (de)
DE (1) DE69936780T2 (de)
WO (1) WO1999064591A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE411386T1 (de) * 1998-07-10 2008-10-15 Fuso Pharmaceutical Ind Antikörper gegen intrazelluläre domänen der protein tyrosin phosphatase
WO2003005953A2 (en) 2001-07-12 2003-01-23 Immunex Corporation Viral proteins capable of binding lar
JP3886968B2 (ja) * 2002-03-18 2007-02-28 日立マクセル株式会社 磁気記録媒体および磁気記録カートリッジ
US7622117B2 (en) 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
EP1799259B1 (de) * 2004-10-12 2012-12-05 Crucell Holland B.V. Bindende moleküle für den nachweis von krebs
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
WO2009100214A2 (en) 2008-02-05 2009-08-13 The Johns Hopkins University Induction of thyroid iodide-handling gene expression in human cancers
EP2291553A4 (de) 2008-05-28 2011-12-14 Genomedx Biosciences Inc Systeme und verfahren zur expressionsbasierten unterscheidung unterschiedlicher klinischer krankheitsstadien bei prostatakrebs
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
CN102272325B (zh) 2008-11-17 2015-07-22 威拉赛特公司 用于疾病诊断的分子表达谱的方法和组合物
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
JP5392707B2 (ja) * 2009-03-31 2014-01-22 株式会社Ｎｔｔドコモ 膜小胞分裂システム
US9206482B2 (en) 2009-04-29 2015-12-08 Genomedx Biosciences Inc. Systems and methods for expression-based classification of thyroid tissue
JP6078339B2 (ja) 2009-05-07 2017-02-08 ベラサイト インコーポレイテッド 甲状腺状態の診断のための方法および組成物
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US8532360B2 (en) 2010-04-20 2013-09-10 Atheropoint Llc Imaging based symptomatic classification using a combination of trace transform, fuzzy technique and multitude of features
US8708914B2 (en) 2010-06-07 2014-04-29 Atheropoint, LLC Validation embedded segmentation method for vascular ultrasound images
US8639008B2 (en) * 2010-04-20 2014-01-28 Athero Point, LLC Mobile architecture using cloud for data mining application
US8485975B2 (en) 2010-06-07 2013-07-16 Atheropoint Llc Multi-resolution edge flow approach to vascular ultrasound for intima-media thickness (IMT) measurement
US8313437B1 (en) 2010-06-07 2012-11-20 Suri Jasjit S Vascular ultrasound intima-media thickness (IMT) measurement system
US20110312520A1 (en) 2010-05-11 2011-12-22 Veracyte, Inc. Methods and compositions for diagnosing conditions
CA2858581A1 (en) 2011-12-13 2013-06-20 Genomedx Biosciences, Inc. Cancer diagnostics using non-coding transcripts
WO2013123097A1 (en) 2012-02-13 2013-08-22 SkyKick, Inc. Migration project automation, e.g., automated selling, planning, migration and configuration of email systems
CA2881627A1 (en) 2012-08-16 2014-02-20 Genomedx Biosciences Inc. Cancer diagnostics using biomarkers
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
WO2014151764A2 (en) 2013-03-15 2014-09-25 Veracyte, Inc. Methods and compositions for classification of samples
WO2016073768A1 (en) 2014-11-05 2016-05-12 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
EP3504348B1 (de) 2016-08-24 2022-12-14 Decipher Biosciences, Inc. Verwendung von genomischen signaturen zur vorhersage des ansprechens von patienten mit prostatakrebs auf postoperative strahlentherapie
US11208697B2 (en) 2017-01-20 2021-12-28 Decipher Biosciences, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
WO2018165600A1 (en) 2017-03-09 2018-09-13 Genomedx Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
AU2018266733A1 (en) 2017-05-12 2020-01-16 Veracyte, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
EP3630836A1 (de) 2017-05-31 2020-04-08 Elstar Therapeutics, Inc. Multispezifische moleküle, die an myeloproliferatives leukämie (mlp)-protein binden, und deren verwendungen
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752583A (en) 1984-11-29 1988-06-21 The United States Of America As Represented By The United States Department Of Energy Monoclonal antibodies to human hemoglobin S and cell lines for the production thereof
US5631151A (en) 1988-10-03 1997-05-20 Biosource Technologies, Inc. Melanin production by transformed organisms
US5538886A (en) * 1990-07-11 1996-07-23 New York University Receptor-type phosphotyrosine phosphatase-alpha
US5888794A (en) 1990-07-11 1999-03-30 New York University Receptor-type phosphotyrosine phosphatase-alpha
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
UA58482C2 (uk) 1994-06-08 2003-08-15 Бьорінгер Інгельхайм Інтернаціональ Гмбх Моноклональне антитіло vff-18 проти сd44v6 і його фрагменти
US5646333A (en) 1994-09-02 1997-07-08 Drexel University Plant promoter useful for directing the expression of foreign proteins to the plant epidermis
ATE411386T1 (de) 1998-07-10 2008-10-15 Fuso Pharmaceutical Ind Antikörper gegen intrazelluläre domänen der protein tyrosin phosphatase

Also Published As

Publication number Publication date
US20050042222A1 (en) 2005-02-24
CA2329776A1 (en) 1999-12-16
EP1092772A1 (de) 2001-04-18
US20050026232A1 (en) 2005-02-03
KR100501550B1 (ko) 2005-07-18
JP3991327B2 (ja) 2007-10-17
US7358061B2 (en) 2008-04-15
AU4060399A (en) 1999-12-30
KR20010052712A (ko) 2001-06-25
AU752642B2 (en) 2002-09-26
US20050008645A1 (en) 2005-01-13
WO1999064591A1 (fr) 1999-12-16
EP1092772B1 (de) 2007-08-08
DE69936780T2 (de) 2008-06-05
EP1460132A1 (de) 2004-09-22
CA2329776C (en) 2009-02-10
ATE369425T1 (de) 2007-08-15
US6846912B1 (en) 2005-01-25
EP1092772A4 (de) 2004-07-07

Similar Documents

Publication Publication Date Title
DE69936780D1 (de) Antikörper gegen eine lar-phosphatase untereinheit
TR199902803T2 (xx) VCAM-1' in te�hisinin daralt�lmas� i�in bile�ikler ve metodlar.
NO20021701L (no) Fremgangsmåte for fremstilling av et konjugat av polyglutamat og et terapeutisk middel
ATE238557T1 (de) Krebsbehandlung
WO2004031411A3 (en) Genes and polypeptides relating to human pancreatic cancers
DE3751809D1 (de) Intraoperative erstellung des befundes und tumor-therapie mittels endoskop
DE60220719D1 (de) Antikörper gegen das muc18-antigen
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
BR0012069A (pt) Composições e métodos para a terapia e diagnóstico de câncer pulmonar
BR9912007A (pt) Composições e métodos para terapia e diagnóstico de câncer de próstata
DE60226499D1 (de) Verwendung von antikörpern gegen das muc18-antigen
WO2005086612A3 (en) Fluorinated carbohydrate conjugates
BRPI0415448A (pt) método de alvejar populações de célula especìfica empregando-se conjugados de maytansinoid de agente de ligação celular ligados por meio de um ligante não-clivável, os referidos conjugados, e métodos de preparação dos referidos conjugados
SI1472541T1 (sl) Prikazovalni agensi in postopek prikazovanja naaladase ali psma
BR0206985A (pt) Anticorpos modificados e métodos de uso
BR0009537A (pt) Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso
DK1084145T3 (da) Antistoffer imod ED-B-domænet i fibronectin, konjugater indeholdende disse og anvendelse deraf til diagnosticering og behandling af tumorer og sygdomme forbundet med angiogenese
WO2001051633A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
CY1109125T1 (el) Θεραπευτικα και διαγνωστικα anti-hsp 70 αντισωματα
DE602004023183D1 (de) Gegen antikörper gerichtete photodynamische therapie
WO2002031209A3 (en) Genes related to development of refractory prostate cancer
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
DE60232244D1 (de) Nachweis und behandlung von prostatakrebs
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
BR0111024A (pt) Composições e métodos para a terapia e diagnóstico de câncer de mama

Legal Events

Date Code Title Description
8364 No opposition during term of opposition